Q1 2016 13F Holders as of 3/31/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
106M
-
Number of holders
-
95
-
Total 13F shares, excl. options
-
33.9M
-
Shares change
-
-209K
-
Total reported value, excl. options
-
$158M
-
Value change
-
-$1.02M
-
Put/Call ratio
-
0
-
Number of buys
-
44
-
Number of sells
-
-33
-
Price
-
$4.68
Significant Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q1 2016
108 filings reported holding CORT - CORCEPT THERAPEUTICS INC - Common Stock as of Q1 2016.
CORCEPT THERAPEUTICS INC - Common Stock (CORT) has 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.9M shares
of 106M outstanding shares and own 31.99% of the company stock.
Largest 10 shareholders include FEDERATED INVESTORS INC /PA/ (14.2M shares), VANGUARD GROUP INC (2.79M shares), BlackRock Institutional Trust Company, N.A. (2.54M shares), MORGAN STANLEY (2.11M shares), INVESTOR AB (1.84M shares), BlackRock Fund Advisors (1.61M shares), STATE STREET CORP (902K shares), NORTHERN TRUST CORP (714K shares), GEODE CAPITAL MANAGEMENT, LLC (494K shares), and Brandywine Global Investment Management, LLC (408K shares).
This table shows the top 95 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.